Sustainability
Piramal Pharma’s GHG Commitment Validated and Approved by SBTi
Piramal Pharma Ltd.
PR-09-24-NI-04Sep 16, 2024
Female-Centric
Transforming Drug Development through a Female Perspective
Chia Chia Sun; William Freimuth, Ph.D., M.D.
Fab Biopharma
PAO-09-24-CL-03Sep 10, 2024
Developability
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Heonchang Lim
Samsung Biologics
PAO-09-24-CL-04Sep 04, 2024
Minitablets
Minitablets: Enhancing Safety and Palatability for Pediatric Medicines
Gus LaBella
Mikart
PAO-09-24-CL-01Aug 30, 2024
Drug Delivery
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Serene Lee
Nice Insight
PAO-09-24-NI-01Aug 30, 2024
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01Aug 07, 2024
Monoclonal Antibodies
Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies
Coriolis Pharma
PR-05-24-NI-02Jun 18, 2024
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02Jun 11, 2024
The PHASE Platform
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
Wheeler Bio
PAO-05-24-CL-01May 08, 2024
Nice Insight API Report
Small Molecule API Discovery and Development Trends
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-01Mar 21, 2024
Digital Pathology
Advancing Disease Research and Drug Development on an Enterprise Pathology Software Platform
Nathan Buchbinder
Proscia
PAO-01-24-CL-2Feb 29, 2024
Advanceability
Right from the Start: Designing Advanceable Formulations and Processes at Phase I
Serán Bioscience
PAO-02-24-CL-09Feb 26, 2024
CDMO - Small Biotech
Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility
Julie Trulson, Ph.D.
PAO-02-24-CL-07Feb 15, 2024
Tech Transfer
Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies
Julie Trulson, Ph.D.
PAO-02-24-CL-06Feb 15, 2024
Translation
The Translational Index Score: Improving the Entire Drug Development Cycle
Jo Varshney, Ph.D., D.V.M.
PAO-02-24-CL-10Feb 15, 2024
CMC
Revolutionizing Early-Stage Biopharma Development: Introducing Wheeler Bio's Portable CMC® Platform
Wheeler Bio
PAO-12-23-CL-04Feb 08, 2024
Synthetic DNA
Is Synthetic Plasmid DNA One of the Solutions for Meeting Growing Demand for Next-Gen Therapies?
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-01-24-NI-04Feb 06, 2024
Genomics
Integrated Spatial Genomics: Real Potential to Provide Truly Novel Biological Insights
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-24-NI-03Jan 30, 2024
Molecular Machines
The Potential of Molecular Machines: Enhanced Drug Delivery and Beyond
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-01-24-NI-02Jan 22, 2024
Drug Development
Podcast: Insights from CDO Experts from Samsung Biologics
Jiyeon Lee; Hyelyoung Jang
Samsung Biologics
POD-01-24-CL-01Jan 16, 2024